Please use this identifier to cite or link to this item: http://hdl.handle.net/10397/76781
PIRA download icon_1.1View/Download Full Text
DC FieldValueLanguage
dc.contributorDepartment of Applied Biology and Chemical Technology-
dc.creatorTang, JCO-
dc.creatorChan, ASC-
dc.creatorLam, KH-
dc.creatorChan, SH-
dc.date.accessioned2018-06-13T02:56:15Z-
dc.date.available2018-06-13T02:56:15Z-
dc.identifier.urihttp://hdl.handle.net/10397/76781-
dc.language.isoenen_US
dc.rightsAssignee: The Hong Kong Polytechnic Universityen_US
dc.titleQuinoline derivatives as anti-cancer agentsen_US
dc.typePatenten_US
dc.description.otherinformationUS9493419; US9493419 B2; US9493419B2; US9,493,419; US 9,493,419 B2; 9493419; Appl. No. 13/334,073en_US
dcterms.abstractQuinoline derivatives showing anticancer activities against cancer cell lines of hepatocellular carcinoma (Hep3B), lung carcinoma (A549), esophageal squamous cell carcinoma (HKESC-1, HKESC-4 and KYSE150). The quinoline derivatives have a backbone structure of the following formulas: ##STR00001##-
dcterms.bibliographicCitationUS Patent 9,493,419 B2. Washington, DC: US Patent and Trademark Office, 2016.-
dcterms.issued2016-11-15-
dc.identifier.ros2016002071-
dc.description.countryUS-
dc.identifier.rosgroupid2016002032-
dc.description.ros2016-2017 > Other Outputs > Patents granted-
dc.description.validate201806 bcrc-
dc.description.oaVersion of Recorden_US
Appears in Collections:Patent
Files in This Item:
File Description SizeFormat 
us9493419b2.pdf1.31 MBAdobe PDFView/Open
Show simple item record

Page views

106
Last Week
2
Last month
Citations as of Dec 7, 2025

Downloads

63
Citations as of Dec 7, 2025

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.